Craig A. Leach

2.0k total citations
24 papers, 1.1k citations indexed

About

Craig A. Leach is a scholar working on Molecular Biology, Oncology and Cell Biology. According to data from OpenAlex, Craig A. Leach has authored 24 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 13 papers in Oncology and 5 papers in Cell Biology. Recurrent topics in Craig A. Leach's work include Ubiquitin and proteasome pathways (13 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer-related Molecular Pathways (4 papers). Craig A. Leach is often cited by papers focused on Ubiquitin and proteasome pathways (13 papers), Peptidase Inhibition and Analysis (6 papers) and Cancer-related Molecular Pathways (4 papers). Craig A. Leach collaborates with scholars based in United States, Canada and United Kingdom. Craig A. Leach's co-authors include Seth J. Goldenberg, Benjamin Nicholson, David L. Brautigan, W. Matthew Michael, Michael R. Mattern, Suresh Kumar, P. Todd Stukenberg, Xufan Tian, William C. Plaxton and Benedikt M. Kessler and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and The Journal of Cell Biology.

In The Last Decade

Craig A. Leach

23 papers receiving 1.1k citations

Peers

Craig A. Leach
Jia-Wei Wu United States
Yong Chi United States
Fengshan Liang United States
Simone Weidlich United Kingdom
Bianca M. Sirbu United States
Joost Schimmel Netherlands
Jia-Wei Wu United States
Craig A. Leach
Citations per year, relative to Craig A. Leach Craig A. Leach (= 1×) peers Jia-Wei Wu

Countries citing papers authored by Craig A. Leach

Since Specialization
Citations

This map shows the geographic impact of Craig A. Leach's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Craig A. Leach with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Craig A. Leach more than expected).

Fields of papers citing papers by Craig A. Leach

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Craig A. Leach. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Craig A. Leach. The network helps show where Craig A. Leach may publish in the future.

Co-authorship network of co-authors of Craig A. Leach

This figure shows the co-authorship network connecting the top 25 collaborators of Craig A. Leach. A scholar is included among the top collaborators of Craig A. Leach based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Craig A. Leach. Craig A. Leach is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Turunen, Brandon J., Craig A. Leach, Terra L. Lasho, et al.. (2024). Preclinical Evaluation of Stx-0712, a CCR2 Cytotoxicity Targeting Chimera (CCR2-CyTAC) for the Treatment of Chronic Myelomonocytic Leukemia. Blood. 144(Supplement 1). 2771–2771.
2.
Marblestone, Jeffrey G., et al.. (2012). Analysis of ubiquitin E3 ligase activity using selective polyubiquitin binding proteins. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(11). 2094–2097. 16 indexed citations
3.
Wu, Jian, et al.. (2012). Bioluminescence assay platform for selective and sensitive detection of Ub/Ubl proteases. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1823(11). 2079–2086. 20 indexed citations
4.
Yagishita, Naoko, Satoko Aratani, Craig A. Leach, et al.. (2012). RING-finger type E3 ubiquitin ligase inhibitors as novel candidates for the treatment of rheumatoid arthritis. International Journal of Molecular Medicine. 30(6). 1281–1286. 43 indexed citations
5.
Altun, Mikael, Holger Kramer, Lianne I. Willems, et al.. (2011). Activity-Based Chemical Proteomics Accelerates Inhibitor Development for Deubiquitylating Enzymes. Chemistry & Biology. 18(11). 1401–1412. 310 indexed citations
6.
Eddins, Michael J., Jeffrey G. Marblestone, Suresh Kumar, et al.. (2011). Targeting the Ubiquitin E3 Ligase MuRF1 to Inhibit Muscle Atrophy. Cell Biochemistry and Biophysics. 60(1-2). 113–118. 46 indexed citations
8.
O’Leary, Brendan M., Eric T. Fedosejevs, Joonho Park, et al.. (2011). Tissue-specific expression and post-translational modifications of plant- and bacterial-type phosphoenolpyruvate carboxylase isozymes of the castor oil plant, Ricinus communis L.. Journal of Experimental Botany. 62(15). 5485–5495. 40 indexed citations
9.
Tian, Xufan, Raymond J. Peroutka, Seth J. Goldenberg, et al.. (2010). Characterization of Selective Ubiquitin and Ubiquitin-Like Protease Inhibitors Using a Fluorescence-Based Multiplex Assay Format. Assay and Drug Development Technologies. 9(2). 165–173. 67 indexed citations
10.
Loc’h, Christian, et al.. (2010). Deubiquitylase, DeSUMOylase, and DeISGylase Activity Microarrays for Assay of Substrate Preference and Functional Modifiers. Molecular & Cellular Proteomics. 10(1). M110.002402–M110.002402. 15 indexed citations
11.
Marblestone, Jeffrey G., Suresh Kumar, Michael J. Eddins, et al.. (2010). Novel Approach for Characterizing Ubiquitin E3 Ligase Function. SLAS DISCOVERY. 15(10). 1220–1228. 14 indexed citations
12.
Cao, Ping, Seth J. Goldenberg, Craig A. Leach, et al.. (2009). Abstract C94: Deubiquitylases as novel anticancer targets: Discovery and development of novel USP7 inhibitors. Molecular Cancer Therapeutics. 8(12_Supplement). C94–C94. 1 indexed citations
13.
Nicholson, Benjamin, Craig A. Leach, Seth J. Goldenberg, et al.. (2008). Characterization of ubiquitin and ubiquitin‐like‐protein isopeptidase activities. Protein Science. 17(6). 1035–1043. 115 indexed citations
14.
Leach, Craig A., Xufan Tian, Michael R. Mattern, & Benjamin Nicholson. (2008). Detection and Characterization of SUMO Protease Activity Using a Sensitive Enzyme-Based Reporter Assay. Methods in molecular biology. 497. 269–281. 9 indexed citations
15.
Uhrig, R. Glen, Yi‐Min She, Craig A. Leach, & William C. Plaxton. (2008). Regulatory Monoubiquitination of Phosphoenolpyruvate Carboxylase in Germinating Castor Oil Seeds. Journal of Biological Chemistry. 283(44). 29650–29657. 60 indexed citations
16.
Leach, Craig A., et al.. (2004). Activation of Aurora-A kinase by protein phosphatase inhibitor-2, a bifunctional signaling protein. Proceedings of the National Academy of Sciences. 101(23). 8625–8630. 95 indexed citations
17.
Leach, Craig A., Shirish Shenolikar, & David L. Brautigan. (2003). Phosphorylation of Phosphatase Inhibitor-2 at Centrosomes during Mitosis. Journal of Biological Chemistry. 278(28). 26015–26020. 33 indexed citations
18.
Eto, Masumi, Craig A. Leach, Nikolaos Tountas, & David L. Brautigan. (2003). Phosphoprotein Inhibitors of Protein Phosphatase-1. Methods in enzymology on CD-ROM/Methods in enzymology. 366. 241–260. 11 indexed citations
19.
Leach, Craig A., Masumi Eto, & David L. Brautigan. (2002). Domains of type 1 protein phosphatase inhibitor-2 required for nuclear and cytoplasmic localization in response to cell-cell contact. Journal of Cell Science. 115(19). 3739–3745. 14 indexed citations
20.
Lerner, Charles P., et al.. (2001). Transgenic mice for the preparation of puromycin-resistant primary embryonic fibroblast feeder layers for embryonic stem cell selection. Mammalian Genome. 12(2). 169–171. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026